Grifols (GIFLF) EBIT Margin Growth (3y) (2013 - 2024)
Powered by 
Analysis
Grifols (GIFLF) EBIT Margin Growth (3y) (2013 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn | -347.00 |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn | -15,844.00 |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn | -377.00 |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn | -204.00 |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn | 7,045.00 |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn | -1,934.00 |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn | 9,003.00 |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn | -2,825.00 |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn | -2.41 Mn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 31,762.00 |
| Dec 31, 2021 | -30,787.00 |
| Dec 31, 2020 | -38,623.00 |
| Mar 31, 2020 | 4,654.00 |
| Dec 31, 2019 | 4,716.00 |
| Mar 31, 2019 | 4,718.00 |
| Dec 31, 2018 | -6,078.00 |
| Jun 30, 2018 | 24.00 |
| Mar 31, 2018 | -211.00 |
| Dec 31, 2017 | -120.00 |
| Jun 30, 2017 | 141.00 |
| Mar 31, 2017 | -426.00 |
| Dec 31, 2016 | -102,570.00 |
| Sep 30, 2016 | -400.00 |
| Jun 30, 2016 | -474.00 |
| Mar 31, 2016 | -327.00 |
| Dec 31, 2015 | -82,600.00 |
| Sep 30, 2015 | -122.00 |
| Jun 30, 2015 | -220.00 |
| Mar 31, 2015 | 36.00 |